Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC

Title
Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC
Authors
Keywords
-
Journal
ONCOLOGIST
Volume 13, Issue 11, Pages 1166-1176
Publisher
Alphamed Press
Online
2008-11-09
DOI
10.1634/theoncologist.2008-0108

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now